Plus Therapeutics (PSTV) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Join SI Premium – FREE
Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.04). Revenue for the quarter came in at $1.4 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
- Morgan Stanley Starts Target Hospitality (TH) at Overweight
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
